Mavrilimumab in Severe COVID-19 Pneumonia and Hyper-inflammation (COMBAT-19)
Clinical trial NCT04397497 · UNKNOWN
Trial details
- NCT number
- NCT04397497
- Sponsor
- Ospedale San Raffaele
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-22
- Primary completion
- 2020-09-22
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.